1. Hebrew University to Collaborate With KYORIN

    Hebrew University to Collaborate With KYORIN

    Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem and KYORIN Pharmaceutical Co., Ltd. (Tokyo, Japan), a subsidiary of KYORIN Holdings, Inc., which is engaged in the development and commercialization of prescription drugs, announced today a strategic collaboration in the discovery of respiratory drug therapies. Under the collaboration, KYORIN will sponsor a research program led by Prof. Francesca Levi-Schaffer of Hebrew University's Institute of Drug Research in the School of Pharmacy, Faculty of Medicine and advance its own drug discovery research with the outcome from the program.

    Prof. Levi-Schaffer specializes in the area of immunopharmacology for allergies ...

    Read Full Article
  1. Categories

    1. News:

      News, Placeholder
  2. Topics Mentioned